Oncosyne
1 known investors
Oncosyne develops the iCAN platform, which uses patient-derived tumoroids (3D lab models of patient tumors) for clinical-grade drug screening and diagnostics in oncology. It offers drug development services to pharmaceutical companies and personalized diagnostic tests for cancer patients, with a first test for colorectal cancer and one under development for pancreatic cancer.
BiotechDigital HealthMedical Devices
Investors · 1
Frequently asked questions
- What does Oncosyne do?
- Oncosyne develops the iCAN platform, which uses patient-derived tumoroids (3D lab models of patient tumors) for clinical-grade drug screening and diagnostics in oncology. It offers drug development services to pharmaceutical companies and personalized diagnostic tests for cancer patients, with a first test for colorectal cancer and one under development for pancreatic cancer.
- Who are Oncosyne's investors?
- Oncosyne's investors include Farvatn Venture.